MetLife Investment Management’s Innovex International INVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.5M | Buy |
663,735
+12,258
| +2% | +$333K | 0.07% | 249 |
|
|
2026
Q1 | $15.9M | Sell |
651,477
-177,280
| -21% | -$4.45M | 0.08% | 235 |
|
|
2025
Q4 | $18.1M | Buy |
828,757
+20,873
| +3% | +$436K | 0.09% | 194 |
|
|
2025
Q3 | $15M | Buy |
807,884
+210,894
| +35% | +$3.51M | 0.07% | 254 |
|
|
2025
Q2 | $9.32M | Buy |
596,990
+576,960
| +2,880% | +$8.87M | 0.05% | 339 |
|
|
2025
Q1 | $360K | Sell |
20,030
-585
| -3% | -$9.94K | ﹤0.01% | 1884 |
|
|
2024
Q4 | $288K | Hold |
20,615
| – | – | ﹤0.01% | 2101 |
|
|
2024
Q3 | $303K | Hold |
20,615
| – | – | ﹤0.01% | 2063 |
|
|
2024
Q2 | $383K | Buy |
20,615
+2,717
| +15% | +$52.7K | ﹤0.01% | 1871 |
|
|
2024
Q1 | $403K | Hold |
17,898
| – | – | ﹤0.01% | 1794 |
|
|
2023
Q4 | $416K | Hold |
17,898
| – | – | ﹤0.01% | 1801 |
|
|
2023
Q3 | $504K | Sell |
17,898
-768
| -4% | -$20.8K | ﹤0.01% | 1632 |
|
|
2023
Q2 | $434K | Hold |
18,666
| – | – | ﹤0.01% | 1790 |
|
|
2023
Q1 | $536K | Hold |
18,666
| – | – | ﹤0.01% | 1598 |
|
|
2022
Q4 | $507K | Hold |
18,666
| – | – | ﹤0.01% | 1637 |
|
|
2022
Q3 | $364K | Buy |
18,666
+1,677
| +10% | +$38.9K | ﹤0.01% | 1870 |
|
|
2022
Q2 | $438K | Sell |
16,989
-2,618
| -13% | -$79.8K | ﹤0.01% | 1757 |
|
|
2022
Q1 | $732K | Buy |
19,607
+6,881
| +54% | +$198K | ﹤0.01% | 1532 |
|
|
2021
Q4 | $250K | Hold |
12,726
| – | – | ﹤0.01% | 1921 |
|
|
2021
Q3 | $320K | Hold |
12,726
| – | – | ﹤0.01% | 1784 |
|
|
2021
Q2 | $431K | Hold |
12,726
| – | – | ﹤0.01% | 1657 |
|
|
2021
Q1 | $423K | Sell |
12,726
-3,273
| -20% | -$112K | ﹤0.01% | 1626 |
|
|
2020
Q4 | $474K | Hold |
15,999
| – | – | ﹤0.01% | 1516 |
|
|
2020
Q3 | $396K | Hold |
15,999
| – | – | ﹤0.01% | 1494 |
|
|
2020
Q2 | $477K | Hold |
15,999
| – | – | 0.01% | 1404 |
|
|
2020
Q1 | $488K | Hold |
15,999
| – | – | 0.01% | 1231 |
|
|
2019
Q4 | $751K | Hold |
15,999
| – | – | 0.01% | 1243 |
|
|
2019
Q3 | $803K | Hold |
15,999
| – | – | 0.01% | 1172 |
|
|
2019
Q2 | $768K | Sell |
15,999
-31,998
| -67% | -$1.39M | 0.01% | 1237 |
|
|
2019
Q1 | $2.2M | Buy |
47,997
+10,232
| +27% | +$402K | 0.01% | 1197 |
|
|
2018
Q4 | $1.13M | Sell |
37,765
-1,169
| -3% | -$47.2K | 0.01% | 971 |
|
|
2018
Q3 | $2.03M | Sell |
38,934
-3,163
| -8% | -$165K | 0.02% | 851 |
|
|
2018
Q2 | $2.16M | Buy |
42,097
+173
| +0.4% | +$8.06K | 0.03% | 769 |
|
|
2018
Q1 | $1.88M | Sell |
41,924
-156
| -0.4% | -$7.63K | 0.02% | 794 |
|
|
2017
Q4 | $2.01M | Buy |
+42,080
| New | +$1.88M | 0.02% | 786 |
|
Other funds holding INVX
BIP
DCM
GI
MetLife Investment Management's INVX Position: Q2 2026 in Review
MetLife Investment Management increased its Innovex International (INVX) stake by 1.9% in Q2 2026, buying an estimated $333K and bringing the position to 663,735 shares worth $16.5M. The position accounts for 0.07% of the portfolio, ranked #249.
MetLife Investment Management first reported a position in INVX in Q4 2017 and has held it in 35 quarters since. The position peaked at $18.1M in Q4 2025. 224 funds tracked by Wall St. Rank hold INVX as of Q2 2026.
- MetLife Investment Management held 663,735 shares of Innovex International worth $16.5M as of Q2 2026.
- MetLife Investment Management bought 12,258 Innovex International shares in Q2 2026, an estimated $333K.
- Innovex International made up 0.07% of MetLife Investment Management's portfolio in Q2 2026, its #249 holding.
- MetLife Investment Management first reported a position in Innovex International in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Innovex International position peaked at $18.1M in Q4 2025.
- 224 funds tracked by Wall St. Rank held Innovex International as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.